289 related articles for article (PubMed ID: 23521871)
21. Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: a post hoc analysis of combined results from 2 double-blind, randomized, placebo-controlled studies.
Weisler RH; Calabrese JR; Thase ME; Arvekvist R; Stening G; Paulsson B; Suppes T
J Clin Psychiatry; 2008 May; 69(5):769-82. PubMed ID: 18452345
[TBL] [Abstract][Full Text] [Related]
22. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study.
El-Khalili N; Joyce M; Atkinson S; Buynak RJ; Datto C; Lindgren P; Eriksson H
Int J Neuropsychopharmacol; 2010 Aug; 13(7):917-32. PubMed ID: 20175941
[TBL] [Abstract][Full Text] [Related]
23. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
[TBL] [Abstract][Full Text] [Related]
24. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
Nasrallah HA; Brecher M; Paulsson B
Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
[TBL] [Abstract][Full Text] [Related]
25. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
[TBL] [Abstract][Full Text] [Related]
26. Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study.
Li H; Ma C; Wang G; Zhu X; Peng M; Gu N
Curr Med Res Opin; 2008 Jan; 24(1):1-10. PubMed ID: 18028587
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of extended-release quetiapine fumarate in youth with bipolar depression: an 8 week, double-blind, placebo-controlled trial.
Findling RL; Pathak S; Earley WR; Liu S; DelBello MP
J Child Adolesc Psychopharmacol; 2014 Aug; 24(6):325-35. PubMed ID: 24956042
[TBL] [Abstract][Full Text] [Related]
28. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM
Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387
[TBL] [Abstract][Full Text] [Related]
29. A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence.
Brown ES; Davila D; Nakamura A; Carmody TJ; Rush AJ; Lo A; Holmes T; Adinoff B; Caetano R; Swann AC; Sunderajan P; Bret ME
Alcohol Clin Exp Res; 2014 Jul; 38(7):2113-8. PubMed ID: 24976394
[TBL] [Abstract][Full Text] [Related]
30. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study).
Weisler RH; Nolen WA; Neijber A; Hellqvist A; Paulsson B;
J Clin Psychiatry; 2011 Nov; 72(11):1452-64. PubMed ID: 22054050
[TBL] [Abstract][Full Text] [Related]
31. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania.
Delbello MP; Schwiers ML; Rosenberg HL; Strakowski SM
J Am Acad Child Adolesc Psychiatry; 2002 Oct; 41(10):1216-23. PubMed ID: 12364843
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial.
Liebowitz M; Lam RW; Lepola U; Datto C; Sweitzer D; Eriksson H
Depress Anxiety; 2010 Oct; 27(10):964-76. PubMed ID: 20734365
[TBL] [Abstract][Full Text] [Related]
33. Quetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies.
Suppes T; Hirschfeld RM; Vieta E; Raines S; Paulsson B
World J Biol Psychiatry; 2008; 9(3):198-211. PubMed ID: 17853277
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of quetiapine-XR as monotherapy or adjunctive therapy to a mood stabilizer in acute bipolar depression with generalized anxiety disorder and other comorbidities: a randomized, placebo-controlled trial.
Gao K; Wu R; Kemp DE; Chen J; Karberg E; Conroy C; Chan P; Ren M; Serrano MB; Ganocy SJ; Calabrese JR
J Clin Psychiatry; 2014 Oct; 75(10):1062-8. PubMed ID: 25007003
[TBL] [Abstract][Full Text] [Related]
35. Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study.
Cookson J; Keck PE; Ketter TA; Macfadden W
Int Clin Psychopharmacol; 2007 Mar; 22(2):93-100. PubMed ID: 17293709
[TBL] [Abstract][Full Text] [Related]
36. Effect of quetiapine XR on depressive symptoms and sleep quality compared with lithium in patients with bipolar depression.
Kim SJ; Lee YJ; Lee YJ; Cho SJ
J Affect Disord; 2014 Mar; 157():33-40. PubMed ID: 24581825
[TBL] [Abstract][Full Text] [Related]
37. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.
Endicott J; Paulsson B; Gustafsson U; Schiöler H; Hassan M
J Affect Disord; 2008 Dec; 111(2-3):306-19. PubMed ID: 18774180
[TBL] [Abstract][Full Text] [Related]
38. Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder.
Katila H; Mezhebovsky I; Mulroy A; Berggren L; Eriksson H; Earley W; Datto C
Am J Geriatr Psychiatry; 2013 Aug; 21(8):769-84. PubMed ID: 23567397
[TBL] [Abstract][Full Text] [Related]
39. Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial.
McIntyre RS; Brecher M; Paulsson B; Huizar K; Mullen J
Eur Neuropsychopharmacol; 2005 Oct; 15(5):573-85. PubMed ID: 16139175
[TBL] [Abstract][Full Text] [Related]
40. A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders.
Brown ES; Garza M; Carmody TJ
J Clin Psychiatry; 2008 May; 69(5):701-5. PubMed ID: 18312058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
